A case study of a 22-year-old patient with cystic fibrosis and identified for phage therapy, found pre-existing phage antibodies. These antibodies may have contributed to clinical failure by effectively neutralizing the phage. www.nature.com/articles/s41...
@jeremyjbarr.bsky.social
A 22-year-old patient with cystic fibrosis and chronic, drug-resistant Bordetella bronchialis infection received compassionate-use phage therapy. Serum samples revealed that pre-existing antiphage imm...
